Remote Irritable Bowel Syndrome (IBS) Monitoring Industry Analysis Report, 2025-2029 & 2034 - Digital Innovations Drive IBS Monitoring Growth Amid Rising Gastrointestinal ...

The "Remote Irritable Bowel Syndrome (IBS) Monitoring Global Market Report 2025" has been added to ResearchAndMarkets.com's offering.
Medindia

Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis

Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures — severity, frequency and stool deferral time — reflecting the spectrum of its ...
The Desert Sun

Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones

This new IP supports crofelemer’s global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in parenteral support requirements with crofelemer ...
Nasdaq

Algernon Pharmaceuticals Appoints Leading Inflammatory Bowel Disease Expert Dr. Walter Reinisch to Its Medical and Scientific Advisory Board

VANCOUVER, British Columbia, April 04, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE:AGN) (FRANKFURT: AGW) (OTCB:BTHCF) (the "Company" or "Algernon") a clinical stage pharmaceutical ...
Science Daily

Exercise shown to release protein reducing bowel cancer risk

Experts have identified for the first time exactly how exercise can lower your risk of getting bowel cancer and slow the growth of tumors. Experts have identified for the first time exactly how ...
Nasdaq

ImmixBio Initiates GMP Manufacturing of IMX-120, a Biologic for Inflammatory Bowel Disease

LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “we” or “us”), a biopharmaceutical company ...